Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 35980-77-9 | MDL No. : | MFCD02945666 |
Formula : | C9H13N3O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ZSXQDGMZXKOADT-UHFFFAOYSA-N |
M.W : | 179.22 | Pubchem ID : | 23818810 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.44 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 54.37 |
TPSA : | 51.38 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.22 cm/s |
Log Po/w (iLOGP) : | 1.43 |
Log Po/w (XLOGP3) : | 0.25 |
Log Po/w (WLOGP) : | 0.13 |
Log Po/w (MLOGP) : | 0.08 |
Log Po/w (SILICOS-IT) : | 0.73 |
Consensus Log Po/w : | 0.52 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.38 |
Solubility : | 7.4 mg/ml ; 0.0413 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.89 |
Solubility : | 23.1 mg/ml ; 0.129 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.85 |
Solubility : | 2.53 mg/ml ; 0.0141 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.13 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | at 200℃; for 1 h; microwave | A suspension of 26a (5.Og, 38.9mmol) in moφholine (13mL) was heated under microwave condition at 2000C for Ih. After being cooled to room temperature, precipitate appeared in the mixture. Ether (45mL) was added and the suspension was stirred for lOmin before being filtered. The filter cake was washed with ether and dried to afford 26b (6.61 g, 95percent). |
87% | at 200℃; for 0.5 h; Irradiation | a) 2-Morpholin-4-yl-pyridin-4-ylamine A stirred mixture of 45.8 g (356 mmol) 4-amino-2-chloropyridine in 124 ml morpholine was heated at 200° C. for 30 min in a microwave oven. The resulting yellow solution was then cooled to room temperature whereupon crystals appeared. 400 ml ether was then added and the suspension stirred for 10 minutes before being filtered. The filter cake was washed with ether and dried to afford 92.9 g of crystalline material (87percent yield of desired product) which 1H NMR analysis revealed to comprise 60 wt percent 2-morpholin-4-yl-pyridin-4-ylamine and 40 wt percent morpholine. |
1 g | at 170℃; for 16 h; | A neat mixture of 2-chloropyridin-4-amine (1.0 g, 7.81 mmol) in morpholine (1 ml) was heated at 170°C for 16 h. The resulting mixture was poured into water (10 ml) and extracted with EtOAc (4 x 10 ml). The collected organic phase was dried over Na2SO4, filtered and concentrated under reduced pressure yielding 2-morpholinopyridin-4-amine (1.0 g, 5.5 mmol). This material was used directly for the next step without further purification. LCMS: Method C, 0.64 mi MS: ES+180.21. |
[ 1429056-38-1 ]
N2-Methylpyridine-2,4-diamine hydrochloride
Similarity: 0.74
[ 861031-56-3 ]
2-Amino-4-morpholin-4-yl-pyrimidine
Similarity: 0.71
[ 1019558-27-0 ]
5-(2-Methyl-1H-imidazol-1-yl)pyridin-2-amine
Similarity: 0.69
[ 62968-37-0 ]
4-(2-Chloropyrimidin-4-yl)morpholine
Similarity: 0.72
[ 861031-56-3 ]
2-Amino-4-morpholin-4-yl-pyrimidine
Similarity: 0.71
[ 260447-04-9 ]
2,6-Dimethyl-4-(5-nitropyridin-2-yl)morpholine
Similarity: 0.71
[ 22177-99-7 ]
4-(6-Chloro-2-methylpyrimidin-4-yl)morpholine
Similarity: 0.66
[ 1429056-38-1 ]
N2-Methylpyridine-2,4-diamine hydrochloride
Similarity: 0.74
[ 260447-04-9 ]
2,6-Dimethyl-4-(5-nitropyridin-2-yl)morpholine
Similarity: 0.71
[ 80827-67-4 ]
1-(3-Methoxypyridin-2-yl)piperazine
Similarity: 0.70